Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long Acting Naltrexone for Opioid Addiction: the Importance of Mental, Physical and Societal Factors for Sustained Abstinence and Recovery

NCT03647774 is registered in ClinicalTrials.gov with Lars Tanum as lead sponsor.

NCT NCT03647774
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03647774 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long Acting Naltrexone for Opioid Addiction: the Importance of Mental, Physical and Societal Factors for Sustained Abstinence and Recovery
Lead sponsor
Lars Tanum
Phase
Phase 4
Overall status
Completed
Start date
August 1, 2018
Completion date
October 13, 2022
Enrollment
317 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

opioid-use disorder